Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1969 1
1970 1
1973 1
1977 2
1979 1
1980 4
1981 4
1982 2
1983 3
1984 2
1985 3
1988 5
1989 5
1990 12
1991 8
1992 17
1993 18
1994 11
1995 6
1996 7
1997 8
1998 15
1999 18
2000 21
2001 22
2002 23
2003 32
2004 36
2005 35
2006 42
2007 40
2008 30
2009 34
2010 25
2011 33
2012 31
2013 36
2014 43
2015 49
2016 48
2017 56
2018 57
2019 63
2020 55
2021 57
2022 72
2023 83
2024 41

Text availability

Article attribute

Article type

Publication date

Search Results

1,129 results

Results by year

Filters applied: . Clear all
Page 1
Novel insights into atopic dermatitis.
Schuler CF 4th, Billi AC, Maverakis E, Tsoi LC, Gudjonsson JE. Schuler CF 4th, et al. J Allergy Clin Immunol. 2023 May;151(5):1145-1154. doi: 10.1016/j.jaci.2022.10.023. Epub 2022 Nov 22. J Allergy Clin Immunol. 2023. PMID: 36428114 Free PMC article. Review.
Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown notable progress. An increasing number of aspects of the immune system are being implicated in AD, including the epithelial barrier, T(H)2 cytokines, and mast cells. ...
Recent research into the pathophysiology and treatment of atopic dermatitis (AD) has shown notable progress. An increasing num …
Biomarkers in atopic dermatitis.
Bakker D, de Bruin-Weller M, Drylewicz J, van Wijk F, Thijs J. Bakker D, et al. J Allergy Clin Immunol. 2023 May;151(5):1163-1168. doi: 10.1016/j.jaci.2023.01.019. Epub 2023 Feb 14. J Allergy Clin Immunol. 2023. PMID: 36792449 Free article. Review.
Atopic dermatitis (AD) is a complex and highly heterogeneous inflammatory skin disease. ...
Atopic dermatitis (AD) is a complex and highly heterogeneous inflammatory skin disease. ...
Atopic dermatitis.
Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Weidinger S, et al. Nat Rev Dis Primers. 2018 Jun 21;4(1):1. doi: 10.1038/s41572-018-0001-z. Nat Rev Dis Primers. 2018. PMID: 29930242 Review.
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease, with a lifetime prevalence of up to 20% and substantial effects on quality of life. ...AD has a strong heritability component and is closely related to and commonly co-occurs with other …
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease, with a lifetime prevalence of up to 20% and subst …
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication.
Napolitano M, Fabbrocini G, Martora F, Genco L, Noto M, Patruno C. Napolitano M, et al. Dermatol Ther. 2022 Dec;35(12):e15901. doi: 10.1111/dth.15901. Epub 2022 Oct 13. Dermatol Ther. 2022. PMID: 36200594 Free PMC article. Review.
Atopic dermatitis (AD) is a chronic inflammatory, itching skin with a significant psychosocial impact on patients and relatives. In adults and adolescents besides flexural eczema, head and neck eczema, and hand eczema, which are the most frequent clinical phenotypes …
Atopic dermatitis (AD) is a chronic inflammatory, itching skin with a significant psychosocial impact on patients and relative …
JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review.
Huang IH, Chung WH, Wu PC, Chen CB. Huang IH, et al. Front Immunol. 2022 Dec 8;13:1068260. doi: 10.3389/fimmu.2022.1068260. eCollection 2022. Front Immunol. 2022. PMID: 36569854 Free PMC article. Review.
Atopic dermatitis (AD) is a chronic, inflammatory, pruritic form of dermatosis with heterogeneous manifestations that can substantially affect patients' quality of life. ...In particular, Th2 cytokines, including interleukin (IL)-4, IL-5, IL-13, IL-31, and th …
Atopic dermatitis (AD) is a chronic, inflammatory, pruritic form of dermatosis with heterogeneous manifestations that can subs …
Comorbidities of atopic dermatitis-what does the evidence say?
Thyssen JP, Halling AS, Schmid-Grendelmeier P, Guttman-Yassky E, Silverberg JI. Thyssen JP, et al. J Allergy Clin Immunol. 2023 May;151(5):1155-1162. doi: 10.1016/j.jaci.2022.12.002. Epub 2023 Jan 6. J Allergy Clin Immunol. 2023. PMID: 36621338 Free article. Review.
Atopic dermatitis (AD) is a common disease that is associated with atopic and nonatopic comorbidities. ...We emphasize the important information provided by studies presenting both relative risk and absolute risk, and show that AD is associated with, among ot …
Atopic dermatitis (AD) is a common disease that is associated with atopic and nonatopic comorbidities. ...We emphasize …
Eczema.
Sohn A, Frankel A, Patel RV, Goldenberg G. Sohn A, et al. Mt Sinai J Med. 2011 Sep-Oct;78(5):730-9. doi: 10.1002/msj.20289. Mt Sinai J Med. 2011. PMID: 21913202 Review.
Atopic dermatitis is a complex disease that arises from interactions between genes and the environment. ...Chronic atopic dermatitis is exemplified by lichenified plaques and papules with excoriations. ...
Atopic dermatitis is a complex disease that arises from interactions between genes and the environment. ...Chronic atopic …
Dupilumab for treatment of atopic dermatitis.
Seegräber M, Srour J, Walter A, Knop M, Wollenberg A. Seegräber M, et al. Expert Rev Clin Pharmacol. 2018 May;11(5):467-474. doi: 10.1080/17512433.2018.1449642. Epub 2018 Mar 20. Expert Rev Clin Pharmacol. 2018. PMID: 29557246 Review.
Dupilumab is a new treatment option for patients with moderate-to-severe atopic dermatitis. It blocks IL-4/IL13-signaling and thereby inhibits receptor signaling downstream the JAK-STAT-pathway. Three of the main disease mechanisms of atopic dermatitis …
Dupilumab is a new treatment option for patients with moderate-to-severe atopic dermatitis. It blocks IL-4/IL13-signaling and …
Atopic dermatitis in children.
Strathie Page S, Weston S, Loh R. Strathie Page S, et al. Aust Fam Physician. 2016 May;45(5):293-6. Aust Fam Physician. 2016. PMID: 27166464 Free article. Review.
BACKGROUND: Atopic dermatitis is a frequent reason for presentation to general practice. ...OBJECTIVE: The aim of this article is to provide an overview of atopic dermatitis management in children in the general practice setting. ...
BACKGROUND: Atopic dermatitis is a frequent reason for presentation to general practice. ...OBJECTIVE: The aim of this article …
Epidemiology of adult atopic dermatitis.
Sacotte R, Silverberg JI. Sacotte R, et al. Clin Dermatol. 2018 Sep-Oct;36(5):595-605. doi: 10.1016/j.clindermatol.2018.05.007. Epub 2018 May 31. Clin Dermatol. 2018. PMID: 30217272 Review.
Atopic dermatitis (AD) is driven by a complex gene-environment interaction. Many of the risk factors and genetic underpinning previously observed for pediatric AD may not apply to adult atopic dermatitis, suggesting that these may largely be different …
Atopic dermatitis (AD) is driven by a complex gene-environment interaction. Many of the risk factors and genetic underpinning …
1,129 results